These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 26384361)

  • 1. Doping in sport and exercise: anabolic, ergogenic, health and clinical issues.
    Bird SR; Goebel C; Burke LM; Greaves RF
    Ann Clin Biochem; 2016 Mar; 53(Pt 2):196-221. PubMed ID: 26384361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The use of drugs to improve athletic performance].
    Kuipers H; Hartgens F
    Ned Tijdschr Geneeskd; 1997 Oct; 141(41):1965-8. PubMed ID: 9550746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of testosterone and anabolic androgenic steroids in sport].
    Medraś M; Jóźków P
    Endokrynol Pol; 2009; 60(3):204-9. PubMed ID: 19569021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of doping in sport: detecting anabolic-androgenic steroids in human fingernail clippings.
    Brown HG; Perrett D
    Med Leg J; 2011; 79(Pt 2):67-9. PubMed ID: 21673061
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of doping agents, particularly anabolic steroids, in sports and society.
    Sjöqvist F; Garle M; Rane A
    Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic steroids in sport: biochemical, clinical and analytical perspectives.
    Kicman AT; Gower DB
    Ann Clin Biochem; 2003 Jul; 40(Pt 4):321-56. PubMed ID: 12880534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the prevalence of anabolic steroids, stimulants, and selected drugs subject to doping controls among elite sport students using analytical chemistry.
    Thevis M; Sauer M; Geyer H; Sigmund G; Mareck U; Schänzer W
    J Sports Sci; 2008 Aug; 26(10):1059-65. PubMed ID: 18608840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
    Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
    Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recruitment to doping and help-seeking behavior of eight female AAS users.
    Börjesson A; Gårevik N; Dahl ML; Rane A; Ekström L
    Subst Abuse Treat Prev Policy; 2016 Mar; 11():11. PubMed ID: 26945991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Netnography and a Survey on Doping Use among Competitive Doping-untested Strength-sport Athletes.
    Jokipalo I; Khudayarov A
    Int J Sports Med; 2021 Jun; 42(7):645-650. PubMed ID: 33506442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of anabolic androgenic steroid use by elite athletes and by members of the general public.
    Anawalt BD
    Mol Cell Endocrinol; 2018 Mar; 464():21-27. PubMed ID: 28943276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
    Tentori L; Graziani G
    Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic steroid use: patterns of use and detection of doping.
    Graham MR; Davies B; Grace FM; Kicman A; Baker JS
    Sports Med; 2008; 38(6):505-25. PubMed ID: 18489196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health.
    Lindqvist AS; Moberg T; Eriksson BO; Ehrnborg C; Rosén T; Fahlke C
    Br J Sports Med; 2013 Oct; 47(15):965-9. PubMed ID: 23613517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Doping: effectiveness, consequences, prevention].
    Guezennec CY
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometric characterization of urinary metabolites of the selective androgen receptor modulator S-22 to identify potential targets for routine doping controls.
    Thevis M; Thomas A; Möller I; Geyer H; Dalton JT; Schänzer W
    Rapid Commun Mass Spectrom; 2011 Aug; 25(15):2187-95. PubMed ID: 21710598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse cardiovascular effects from the use of anabolic-androgenic steroids as ergogenic resources.
    Santos MA; Oliveira CV; Silva AS
    Subst Use Misuse; 2014 Jul; 49(9):1132-7. PubMed ID: 24832723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anabolic steroids in sport.
    VanHelder WP; Kofman E; Tremblay MS
    Can J Sport Sci; 1991 Dec; 16(4):248-57. PubMed ID: 1663826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.